Banco Macro S.A. (BMA) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$74.87
Price Target
$130.00
Target Range
$130.00 — $130.00
Analyst Rating
Buy
Forward P/E0.0x
Trailing P/E20.4x
Forward PEG0.00
Implied Growth+86.9%
Median Target$130.00
Analyst Spread0.0%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$130
+73.6%
Consensus
$130
+73.6%
Bull Case
$130
+73.6%
Valuation Model TargetsConfidence: 44/100
Bear$193165
Base$116638
Bull$649549
BMA Price Target Analysis
Updated May 8, 2026As of May 8, 2026, Banco Macro S.A. (BMA) has a Wall Street consensus price target of $130.00, based on estimates from 14 covering analysts. With the stock currently trading at $74.87, this represents a potential upside of +73.6%. The company has a market capitalization of $4.70B.
Analyst price targets range from a low of $130.00 to a high of $130.00, representing a 0% spread in expectations. The median target of $130.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 6 analysts rating the stock as a Buy or Strong Buy,6 rating it Hold, and 2 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, BMA trades at a trailing P/E of 20.4x and forward P/E of 0.0x. The forward PEG ratio of 0.00 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow +86.9% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $116637.52, with bear and bull scenarios of $193165.37 and $649549.22 respectively. Model confidence stands at 44/100, suggesting limited visibility into future performance.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Financial Services stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+2.2%
Avg Forward P/E1.9x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 GGALGrupo Financiero Galicia S.A. | $5.7B | $43.24 | $60.50 | +39.9% | Buy | 0.0x | 12 |
 SUPVGrupo Supervielle S.A. | $751M | $8.58 | $7.00 | -18.4% | Sell | 0.0x | 8 |
 BBARBanco BBVA Argentina S.A. | $3.1B | $15.36 | $16.00 | +4.2% | Buy | 0.0x | 3 |
 CEPUCentral Puerto S.A. | $2.2B | $14.59 | $12.00 | -17.8% | Hold | 0.0x | 4 |
 ITUBItaú Unibanco Holding S.A. | $90.2B | $8.18 | $6.38 | -22.0% | Buy | 1.7x | 12 |
 BBDBanco Bradesco S.A. | $39.6B | $3.74 | $3.20 | -14.4% | Hold | 1.4x | 15 |
 BSACBanco Santander-Chile | $14.4B | $30.53 | $33.50 | +9.7% | Hold | 0.0x | 12 |
 BAPCredicorp Ltd. | $25.5B | $321.47 | $408.00 | +26.9% | Hold | 3.4x | 15 |
 SIDCompanhia Siderúrgica Nacional | $1.8B | $1.35 | $1.40 | +3.7% | Sell | 12.1x | 5 |
 YPFYPF Sociedad Anónima | $16.8B | $42.80 | $47.00 | +9.8% | Buy | 0.0x | 15 |
Upside Potential Comparison
GGALBAPYPFBSACBBARSIDBBDCEPUSee BMA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BMA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BMA vs BRK-A
Side-by-side business, growth, and profitability comparison vs Berkshire Hathaway Inc..
Start ComparisonBMA — Frequently Asked Questions
Quick answers to the most common questions about buying BMA stock.
What is the BMA stock price target for 2026?
The consensus Wall Street price target for BMA is $130, representing 73.6% upside from the current price of $74.87. With 14 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
Is BMA a buy, sell, or hold?
BMA has a consensus rating of "Buy" based on 14 Wall Street analysts. The rating breakdown is mixed, with 6 Hold ratings making up the largest segment. The consensus 12-month price target of $130 implies 73.6% upside from current levels.
Is BMA stock overvalued or undervalued?
With a forward P/E of 0.0088x, BMA trades at a relatively low valuation. The consensus target of $130 implies 73.6% appreciation, suggesting meaningful undervaluation.
How high can BMA stock go?
The most bullish Wall Street analyst has a price target of $130 for BMA, while the most conservative target is $130. The consensus of $130 represents the median expectation. Our quantitative valuation model projects a bull case target of $649549 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover BMA stock?
BMA is moderately covered, with 14 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 6 have Buy ratings, 6 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the BMA stock forecast?
The 12-month BMA stock forecast based on 14 Wall Street analysts shows a consensus price target of $130, with estimates ranging from $130 (bear case) to $130 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $116638, with bear/bull scenarios of $193165/$649549.
What is BMA's fair value based on fundamentals?
Our quantitative valuation model calculates BMA's fair value at $116638 (base case), with a bear case of $193165 and bull case of $649549. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 44/100.
What is BMA's forward P/E ratio?
BMA trades at a forward P/E ratio of 0.0x based on next-twelve-months earnings estimates compared to a trailing P/E of 20.4x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy BMA stock?
Wall Street analysts are very optimistic on BMA, with a "Buy" consensus rating and $130 price target (73.6% upside). 6 of 14 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do BMA price targets vary so much?
BMA analyst price targets range from $130 to $130, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $130 consensus represents the middle ground. Our model's $193165-$649549 range provides an independent fundamental perspective.